News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
524,402 Results
Type
Article (34657)
Company Profile (190)
Press Release (489555)
Section
Business (148871)
Career Advice (812)
Deals (25986)
Drug Delivery (104)
Drug Development (57482)
Employer Resources (98)
FDA (12650)
Job Trends (12416)
News (252930)
Policy (27028)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (3)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2238)
Academic (2)
Accelerated approval (3)
Adcomms (15)
Allergies (66)
Alliances (39671)
ALS (62)
Alzheimer's disease (1051)
Antibody-drug conjugate (ADC) (74)
Approvals (12689)
Artificial intelligence (232)
Autoimmune disease (14)
Automation (10)
Bankruptcy (237)
Best Places to Work (10064)
BIOSECURE Act (12)
Biosimilars (96)
Biotechnology (92)
Bladder cancer (39)
Brain cancer (22)
Breast cancer (178)
Cancer (1333)
Cardiovascular disease (148)
Career advice (724)
Career pathing (17)
CAR-T (63)
Cell therapy (227)
Cervical cancer (15)
Clinical research (47204)
Collaboration (600)
Compensation (180)
Complete response letters (18)
COVID-19 (2361)
CRISPR (31)
C-suite (182)
Cystic fibrosis (73)
Data (1466)
Decentralized trials (2)
Denatured (26)
Depression (31)
Diabetes (200)
Diagnostics (5264)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (25)
Drug discovery (90)
Drug pricing (106)
Drug shortages (17)
Duchenne muscular dystrophy (56)
Earnings (53307)
Editorial (25)
Employer branding (10)
Employer resources (86)
Events (88646)
Executive appointments (601)
FDA (13578)
Featured Employer (41)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (572)
Gene editing (64)
Generative AI (24)
Gene therapy (197)
GLP-1 (574)
Government (4452)
Grass and pollen (4)
Guidances (41)
Healthcare (16028)
Huntington's disease (13)
IgA nephropathy (17)
Immunology and inflammation (71)
Indications (21)
Infectious disease (2493)
Inflammatory bowel disease (105)
Inflation Reduction Act (10)
Influenza (49)
Intellectual property (64)
Interviews (100)
IPO (10912)
IRA (43)
Job creations (2803)
Job search strategy (653)
Kidney cancer (6)
Labor market (16)
Layoffs (282)
Leadership (8)
Legal (5834)
Liver cancer (47)
Lung cancer (188)
Lymphoma (95)
Machine learning (4)
Management (35)
Manufacturing (224)
MASH (50)
Medical device (9685)
Medtech (9689)
Mergers & acquisitions (15462)
Metabolic disorders (537)
Multiple sclerosis (56)
NASH (16)
Neurodegenerative disease (57)
Neuropsychiatric disorders (16)
Neuroscience (1426)
NextGen: Class of 2025 (5623)
Non-profit (4048)
Northern California (1697)
Now hiring (11)
Obesity (295)
Opinion (174)
Ovarian cancer (41)
Pain (71)
Pancreatic cancer (37)
Parkinson's disease (95)
Partnered (16)
Patents (146)
Patient recruitment (77)
Peanut (34)
People (46844)
Pharmaceutical (83)
Pharmacy benefit managers (17)
Phase I (14049)
Phase II (19891)
Phase III (16532)
Pipeline (804)
Podcasts (73)
Policy (110)
Postmarket research (2079)
Preclinical (5322)
Press Release (50)
Prostate cancer (72)
Psychedelics (26)
Radiopharmaceuticals (194)
Rare diseases (292)
Real estate (4416)
Recruiting (40)
Regulatory (18404)
Reports (22)
Research institute (2076)
Resumes & cover letters (85)
Rett syndrome (3)
RNA editing (3)
RSV (33)
Schizophrenia (57)
Series A (96)
Series B (65)
Service/supplier (7)
Sickle cell disease (50)
Southern California (1500)
Special edition (11)
Spinal muscular atrophy (119)
Sponsored (19)
Startups (2802)
State (2)
Stomach cancer (5)
Supply chain (52)
Tariffs (14)
The Weekly (45)
United States (16250)
Vaccines (581)
Venture capitalists (28)
Webinars (11)
Weight loss (187)
Women's health (34)
Worklife (8)
Date
Today (100)
Last 7 days (405)
Last 30 days (1983)
Last 365 days (25430)
2025 (6817)
2024 (26673)
2023 (30050)
2022 (40560)
2021 (44444)
2020 (44481)
2019 (38943)
2018 (29496)
2017 (24537)
2016 (25014)
2015 (28776)
2014 (22728)
2013 (18567)
2012 (19850)
2011 (20543)
2010 (18490)
Location
Africa (647)
Alabama (31)
Alaska (6)
Arizona (140)
Arkansas (11)
Asia (31465)
Australia (5142)
California (3904)
Canada (1498)
China (364)
Colorado (182)
Connecticut (203)
Delaware (86)
Europe (67002)
Florida (624)
Georgia (166)
Hawaii (1)
Idaho (39)
Illinois (434)
India (23)
Indiana (286)
Iowa (5)
Japan (128)
Kansas (92)
Kentucky (23)
Louisiana (10)
Maine (67)
Maryland (692)
Massachusetts (3107)
Michigan (151)
Minnesota (268)
Mississippi (2)
Missouri (79)
Montana (16)
Nebraska (20)
Nevada (48)
New Hampshire (53)
New Jersey (1348)
New Mexico (16)
New York (1222)
North Carolina (755)
North Dakota (4)
Northern California (1697)
Ohio (139)
Oklahoma (13)
Oregon (34)
Pennsylvania (1003)
Puerto Rico (9)
Rhode Island (21)
South America (922)
South Carolina (12)
South Dakota (1)
Southern California (1500)
Tennessee (88)
Texas (569)
Utah (151)
Virginia (121)
Washington D.C. (58)
Washington State (417)
West Virginia (3)
Wisconsin (48)
524,402 Results for "emerald health pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Okogen Announces Regulatory Submission to CDSCO for EMERALD STUDY and Appointment of New Chief Medical Officer
April 2, 2025
·
2 min read
Press Releases
NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients
February 24, 2025
·
4 min read
Government
Democrats Push Back on Trump Health Cuts With Lawsuits and Longest Ever Senate Speech
Nearly two dozen states on Tuesday sued the Department of Health and Human Services over a planned $11 billion funding cut for public health projects while New Jersey Senator Cory Booker spoke for 25 hours in protest of Trump administration policies.
April 2, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Aspen Neuroscience to Partner with Rune Labs and Emerald Innovations to Incorporate both Active and Passive Digital Health Monitoring in Trial Ready Cohort Screening Study
Aspen Neuroscience announced that it is partnering with Emerald Innovations, a pioneer in the creation of “invisible” off-body sensors for measuring health analytics, and Rune Labs, a software and data analytics company for precision neurology, to incorporate digital health modalities in the company’s Trial-Ready Screening Cohort Study.
August 24, 2023
·
6 min read
Press Releases
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
April 9, 2025
·
5 min read
Deals
Skye Bioscience Closes Acquisition of Emerald Health Therapeutics
Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has concluded the merger transaction with Emerald Health Therapeutics (“Emerald”). Both companies’ shareholders voted in favor of the transaction and the Supreme Court of British Columbia approved the transaction.
November 11, 2022
·
17 min read
Business
“Perfect Patient” Industry Burdens; Exits and Investment in Women’s Health
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss the challenges of inclusion and exclusion criteria of clinical trial patients, and reflect on current investment approaches around women’s health.
March 13, 2025
·
1 min read
·
Lori Ellis
Press Releases
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
1 min read
Business
Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b Proof-of-Concept Clinical Trial
Verge Genomics announced that Emerald Innovations’ wireless digital health technology will be used to capture critical patient data in its planned Phase 1b proof-of-concept study of the PIKfyve inhibitor VRG50635, a novel therapeutic in clinical development for amyotrophic lateral sclerosis (ALS).
May 23, 2023
·
4 min read
Drug Development
Emerald Health Pharmaceuticals Receives Safety Review Committee Approval to Proceed to Final Cohorts of EHP-101 Phase 2a Systemic Sclerosis Trial
Emerald Health Pharmaceuticals Inc. has received a positive safety review following a pre-specified interim analysis by the Safety Review Committee (“SRC”) of its Phase 2a study of EHP-101 for systemic sclerosis (“SSc”).
January 11, 2023
·
6 min read
1 of 52,441
Next